Details for New Drug Application (NDA): 216003
The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There is one drug master file entry for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Summary for 216003
| Tradename: | SUCCINYLCHOLINE CHLORIDE |
| Applicant: | Be Pharms |
| Ingredient: | succinylcholine chloride |
| Patents: | 0 |
Pharmacology for NDA: 216003
| Physiological Effect | Neuromuscular Depolarizing Blockade |
Medical Subject Heading (MeSH) Categories for 216003
Suppliers and Packaging for NDA: 216003
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 216003 | ANDA | Nordic Pharma, Inc. | 69918-700 | 69918-700-12 | 10 VIAL, MULTI-DOSE in 1 CARTON (69918-700-12) / 10 mL in 1 VIAL, MULTI-DOSE (69918-700-05) |
| SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 216003 | ANDA | Nordic Pharma, Inc. | 69918-700 | 69918-700-29 | 25 VIAL, MULTI-DOSE in 1 CARTON (69918-700-29) / 10 mL in 1 VIAL, MULTI-DOSE (69918-700-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
| Approval Date: | Feb 7, 2022 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
